Adverse events and preventive measures related to COVID-19 vaccines
Authors:
Open Access
- 13 September 2021
- journal article
- research article
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 8 (3) , 153-159
Abstract
The coronavirus disease 2019 (COVID-19) vaccines are categorized according to the manufacturing technique, including mRNA vaccines and adenovirus vector vaccines. According to previous studies, the reported efficacy of the COVID-19 vaccine is excellent regardless of the type of vaccine, and the majority of studies have shown similar results for safety. Most of the adverse reactions after vaccination were mild or moderate grade, and severe reactions were reported in a very small proportion. However, the adverse reactions that might occur after nationwide vaccinations can contribute to crowding of emergency departments, and this can further lead to significant obstacles to providing necessary treatment for life-threatening conditions. Therefore, as emergency physicians, we would like to present some concerns and suggestions to prevent these predictable problems.Keywords
This publication has 43 references indexed in Scilit:
- Chimpanzee Adenovirus Vector Ebola VaccineNew England Journal of Medicine, 2017
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola VaccinesJAMA, 2016
- Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccinationVaccine, 2015
- Polio endgame: the global introduction of inactivated polio vaccineExpert Review of Vaccines, 2015
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative ImmunogenicityPLOS ONE, 2012
- Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoringVaccine, 2009
- Systematic Review of Emergency Department Crowding: Causes, Effects, and SolutionsAnnals of Emergency Medicine, 2008
- Twenty years of research on cytokine-induced sickness behaviorBrain, Behavior, and Immunity, 2007
- Adenoviruses as vaccine vectorsMolecular Therapy, 2004
- Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for useExpert Review of Vaccines, 2002